Zhejiang Shengda Pharm Tangible Net Worth Ratio
Zhejiang Shengda Pharm tangible net worth ratio. Zhejiang Shengda Pharm (603079) has a Tangible Net Worth Ratio of 86.4% as of March 2026. This metric is calculated by deducting intangible assets (CN¥221.25 Million) from net assets (CN¥1.63 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Zhejiang Shengda Pharm (603079) net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Zhejiang Shengda Pharm (2012–2025)
Tangible net worth ratio of Zhejiang Shengda Pharm from 2012 to 2025. This chart shows how Zhejiang Shengda Pharm's Tangible Net Worth Ratio has changed across 14 annual periods from 2012 to 2025. As of March 2026, the ratio stands at 86.4%, reflecting net assets of CN¥1.63 Billion with intangible assets of CN¥221.25 Million CNY. Check asset allocation strategy of Zhejiang Shengda Pharm to assess the company's strategic physical and investment asset allocation.
Zhejiang Shengda Pharm Tangible Net Worth Ratio by Year (2012–2025)
Zhejiang Shengda Pharm tangible net worth ratio by year from 2012 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Zhejiang Shengda Pharm from 2012 to 2025, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Zhejiang Shengda Pharm market capitalisation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 86.2% | CN¥1.61 Billion | CN¥222.94 Million | CN¥2.20 Billion | ▲ +3.8 pp |
| 2024 | 82.4% | CN¥1.28 Billion | CN¥225.58 Million | CN¥1.79 Billion | ▲ +0.7 pp |
| 2023 | 81.7% | CN¥1.27 Billion | CN¥231.82 Million | CN¥1.72 Billion | ▼ -2.0 pp |
| 2022 | 83.8% | CN¥1.34 Billion | CN¥218.20 Million | CN¥1.66 Billion | ▼ -4.6 pp |
| 2021 | 88.3% | CN¥1.34 Billion | CN¥156.09 Million | CN¥1.76 Billion | ▲ +0.8 pp |
| 2020 | 87.5% | CN¥1.33 Billion | CN¥165.59 Million | CN¥1.70 Billion | ▲ +6.8 pp |
| 2019 | 80.7% | CN¥911.71 Million | CN¥175.60 Million | CN¥1.53 Billion | ▼ -3.7 pp |
| 2018 | 84.5% | CN¥828.42 Million | CN¥128.82 Million | CN¥1.25 Billion | ▲ +0.0 pp |
| 2017 | 84.4% | CN¥768.71 Million | CN¥119.90 Million | CN¥985.98 Million | ▲ +13.5 pp |
| 2016 | 70.9% | CN¥440.02 Million | CN¥128.02 Million | CN¥741.37 Million | ▲ +1.5 pp |
| 2015 | 69.4% | CN¥439.09 Million | CN¥134.34 Million | CN¥624.13 Million | ▲ +3.9 pp |
| 2014 | 65.5% | CN¥324.87 Million | CN¥112.06 Million | CN¥548.27 Million | ▲ +7.8 pp |
| 2013 | 57.7% | CN¥281.09 Million | CN¥118.91 Million | CN¥505.09 Million | ▲ +26.0 pp |
| 2012 | 31.7% | CN¥185.99 Million | CN¥127.03 Million | CN¥507.42 Million | — |